Integer Holdings (NYSE: ITGR) announced today that it has completed its purchase of Oscor — a deal that expands the capabilities of what was already one of the world’s largest medtech contract manufacturers.
Integer said the acquisition would cost $220 million when it first announced its plans in October.
Oscor is the creator and marketer of various specialized implantable cardiac pacing and neurostimulation leads, venous access systems and diagnostic catheters. Integer officials note that Oscor’s finished introducer systems, guiding sheaths and proprietary lead wire technologies give it even more exposure to higher-growth markets — including cardiac pacing, electrophysiology, neurostimulation, cardiovascular, peripheral vascular and structural heart.
Integer’s Oscor acquisition adds design, development and manufacturing operations in Palm Harbor, Florida and the Dominican Republic, business offices in Germany and 900 employees.
“The acquisition of Oscor strengthens Integer’s ability to serve our customers by expanding our product offering in steerable sheaths and cardiac and neurostimulation leads and adding low-cost manufacturing capacity to support growth,” Integer CEO Joe Dziedzic said in a news release. “The addition of Oscor’s strong brand will deepen our relationships with existing customers, bring new customers to Integer, and allow us to build relationships with several emerging growth companies.”
